Moshe Manor is President at Protalix BioTherapeutics, Inc. (PLX). They have made 1 open-market trade across 1 company since 2017, most recently 2017-05-16.
CIK 0001623532
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $41K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PLX | 50,000 | $131K |
Shares reported on the most recent Form 4, priced at the 2017-05-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLX | BUY | 2017-05-16 | 2017-05-16 | $0.81 | $41K | +11.2% | -1.5% | -30.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.